Zobrazeno 1 - 10
of 5 084
pro vyhledávání: '"Kruisbeek, A."'
Autor:
Haoxiao Zuo, Marie-José C. van Lierop, Jorn Kaspers, Remco Bos, Anneke Reurs, Saheli Sarkar, Tania Konry, Alwin Kamermans, Gijs Kooij, Helga E. de Vries, Tanja D. de Gruijl, Alex Karlsson-Parra, Erik H. Manting, Ada M. Kruisbeek, Satwinder Kaur Singh
Publikováno v:
Cells, Vol 10, Iss 11, p 3233 (2021)
DCP-001 is a cell-based cancer vaccine generated by differentiation and maturation of cells from the human DCOne myeloid leukemic cell line. This results in a vaccine comprising a broad array of endogenous tumor antigens combined with a mature dendri
Externí odkaz:
https://doaj.org/article/467c11dcb8d4413a8aaeb2c376d6e894
Autor:
Bischof, Felix, Wienhold, Wolfgang, Wirblich, Christoph, Malcherek, Georg, Zevering, Olayinka, Kruisbeek, Ada M., Melms, Arthur
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 2001 Oct 01. 98(21), 12168-12173.
Externí odkaz:
https://www.jstor.org/stable/3056867
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 1999 Jan . 96(2), 622-627.
Externí odkaz:
https://www.jstor.org/stable/46861
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 1996 Jun 01. 93(12), 6135-6139.
Externí odkaz:
https://www.jstor.org/stable/39688
Autor:
K. Tan
Publikováno v:
Cell Biochemistry and Function. 9:295-295
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1454037bac79beb82d5becaafe0e95d2
https://doi.org/10.1002/cbf.290090416
https://doi.org/10.1002/cbf.290090416
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ada M. Kruisbeek, Tanja D. de Gruijl, Malika Koppes, Jorn Kaspers, Sandra van Wetering, Gert J. Ossenkoppele, Arjan A. van de Loosdrecht, Saskia J. A. M. Santegoets, Yvonne den Hartog, Corien Eeltink, Satwinder Kaur Singh
Publikováno v:
Cancer Immunology, Immunotherapy
Cancer Immunology and Immunotherapy, 67(10), 1505-1518. Springer Science and Business Media Deutschland GmbH
van de Loosdrecht, A A, van Wetering, S, Santegoets, S J A M, Singh, S K, Eeltink, C M, den Hartog, Y, Koppes, M, Kaspers, J, Ossenkoppele, G J, Kruisbeek, A M & de Gruijl, T D 2018, ' A novel allogeneic off-the-shelf dendritic cell vaccine for post-remission treatment of elderly patients with acute myeloid leukemia ', Cancer Immunology and Immunotherapy, vol. 67, no. 10, pp. 1505-1518 . https://doi.org/10.1007/s00262-018-2198-9
Cancer Immunology, Immunotherapy, 67(10), 1505-1518
Cancer Immunology and Immunotherapy, 67(10), 1505-1518. Springer Science and Business Media Deutschland GmbH
van de Loosdrecht, A A, van Wetering, S, Santegoets, S J A M, Singh, S K, Eeltink, C M, den Hartog, Y, Koppes, M, Kaspers, J, Ossenkoppele, G J, Kruisbeek, A M & de Gruijl, T D 2018, ' A novel allogeneic off-the-shelf dendritic cell vaccine for post-remission treatment of elderly patients with acute myeloid leukemia ', Cancer Immunology and Immunotherapy, vol. 67, no. 10, pp. 1505-1518 . https://doi.org/10.1007/s00262-018-2198-9
Cancer Immunology, Immunotherapy, 67(10), 1505-1518
In elderly acute myeloid leukemia (AML) patients post-remission treatment options are associated with high comorbidity rates and poor survival. Dendritic cell (DC)-based immunotherapy is a promising alternative treatment strategy. A novel allogeneic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef36f686f0fe8c6ea1435348e856c7c3
https://doi.org/10.1007/s00262-018-2198-9
https://doi.org/10.1007/s00262-018-2198-9
Autor:
Remco Bos, Ada M. Kruisbeek, Anneke W. Reurs, Saheli Sarkar, G. Kooij, Jorn Kaspers, Erik Manting, Helga E. de Vries, Haoxiao Zuo, Alwin Kamermans, Alex Karlsson-Parra, Marie-José van Lierop, Satwinder Kaur Singh, Tania Konry, Tanja D. de Gruijl
Publikováno v:
Cells, 10(11):3233. MDPI Multidisciplinary Digital Publishing Institute
Cells, Vol 10, Iss 3233, p 3233 (2021)
Cells
Cells, 10(11). MDPI Multidisciplinary Digital Publishing Institute
Zuo, H, van Lierop, M-J C, Kaspers, J, Bos, R, Reurs, A, Sarkar, S, Konry, T, Kamermans, A, Kooij, G, de Vries, H E, de Gruijl, T D, Karlsson-Parra, A, Manting, E H, Kruisbeek, A M & Singh, S K 2021, ' Transfer of Cellular Content from the Allogeneic Cell-Based Cancer Vaccine DCP-001 to Host Dendritic Cells Hinges on Phosphatidylserine and Is Enhanced by CD47 Blockade ', Cells, vol. 10, no. 11, 3233 . https://doi.org/10.3390/cells10113233
Volume 10
Issue 11
Cells, Vol 10, Iss 3233, p 3233 (2021)
Cells
Cells, 10(11). MDPI Multidisciplinary Digital Publishing Institute
Zuo, H, van Lierop, M-J C, Kaspers, J, Bos, R, Reurs, A, Sarkar, S, Konry, T, Kamermans, A, Kooij, G, de Vries, H E, de Gruijl, T D, Karlsson-Parra, A, Manting, E H, Kruisbeek, A M & Singh, S K 2021, ' Transfer of Cellular Content from the Allogeneic Cell-Based Cancer Vaccine DCP-001 to Host Dendritic Cells Hinges on Phosphatidylserine and Is Enhanced by CD47 Blockade ', Cells, vol. 10, no. 11, 3233 . https://doi.org/10.3390/cells10113233
Volume 10
Issue 11
DCP-001 is a cell-based cancer vaccine generated by differentiation and maturation of cells from the human DCOne myeloid leukemic cell line. This results in a vaccine comprising a broad array of endogenous tumor antigens combined with a mature dendri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19cff7c9de1aae846c1da1ceefff581a
https://doi.org/10.3390/cells10113233
https://doi.org/10.3390/cells10113233
Publikováno v:
Science, 1990 Dec . 250(4988), 1726-1729.
Externí odkaz:
https://www.jstor.org/stable/2878553
Autor:
Lew, Andrew M., Pardoll, Drew M., Maloy, W. Lee, Fowlkes, B. J., Kruisbeek, Ada, Cheng, Shi-Fey, Germain, Ronald N., Bluestone, Jeffrey A., Schwartz, Ronald H., Coligan, John E.
Publikováno v:
Science, 1986 Dec 01. 234(4782), 1401-1405.
Externí odkaz:
https://www.jstor.org/stable/1698206